WallStreetZenWallStreetZen

NASDAQ: RCKT
Rocket Pharmaceuticals Inc Stock Ownership - Who owns Rocket Pharmaceuticals?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Rocket Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
John MilitelloVice President of Finance Treasurer Principal Accounting Officer2024-04-22833$22.87
$19.05kSell
David P. SouthwellDirector2024-04-1529,624$4.34
$128.63kBuy
David P. SouthwellDirector2024-04-1510,000$24.05
$240.52kSell
David P. SouthwellDirector2024-04-1259,716$24.22
$1.45MSell
David P. SouthwellDirector2024-04-1210,284$25.16
$258.70kSell
David P. SouthwellDirector2024-04-1270,000$4.34
$303.94kBuy
Mark Andrew WhiteGeneral Manager Commercial Affairs2024-04-0812,532$24.64
$308.76kSell
John MilitelloVP Principal Accounting Officer and Interim Principal Financial Officer2024-03-212,490$28.10
$69.98kSell
Gotham MakkerDirector2024-03-21274,000$28.43
$7.79MSell
Martin WilsonGeneral Counsel2024-02-294,100$29.33
$120.26kSell

1 of 4

RCKT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RCKT insiders and whales buy or sell their stock.

RCKT Shareholders

What type of owners hold Rocket Pharmaceuticals Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Rtw Investments LP37.14%33,617,724$723.45MInsider
Rtw Investments LP19.54%17,687,772$380.64MInstitution
Roderick Wong17.98%16,272,635$350.19MInsider
Wellington Management Group LLP9.06%8,197,546$176.41MInstitution
Blackrock Inc6.55%5,930,178$127.62MInstitution
Vanguard Group Inc6.02%5,447,565$117.23MInstitution
Maverick Capital Ltd4.46%4,034,068$86.81MInstitution
Westfield Capital Management Co LP4.36%3,941,859$84.83MInstitution
Devon Park Associates LP3.59%3,253,566$70.02MInsider
Devang Kantesaria3.58%3,243,709$69.80MInsider

1 of 3

RCKT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RCKT54.89%45.11%Net SellingNet Selling
RNA82.47%17.53%Net SellingNet Selling
KROS70.92%29.08%Net Buying
MRVI35.06%64.94%Net SellingNet Selling
NAMS60.05%39.95%Net SellingNet Selling
View Top Biotech Stocks

Rocket Pharmaceuticals Stock Ownership FAQ

Who owns Rocket Pharmaceuticals?

Rocket Pharmaceuticals (NASDAQ: RCKT) is owned by 98.33% institutional shareholders, 80.81% Rocket Pharmaceuticals insiders, and 0.00% retail investors. Rtw Investments LP is the largest individual Rocket Pharmaceuticals shareholder, owning 33.62M shares representing 37.14% of the company. Rtw Investments LP's Rocket Pharmaceuticals shares are currently valued at $757.41M.

If you're new to stock investing, here's how to buy Rocket Pharmaceuticals stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.